Breakthrough for Women’s Fertility: Fresenius Kabi Offers Accessibly-Priced Treatment

Fresenius Kabi is proud to announce the immediate launch of Ganirelix Acetate Injection, its generic injectable fertility drug. With this introduction to the women’s health market, Fresenius Kabi enables more women to receive reliable treatments with their 250 mcg/0.5 mL prefilled syringes. Ganirelix Acetate Injection is an important step in advancing women’s healthcare and fertility options.

Ganirelix Acetate Injection is a medication used to control hormonal surges in women undergoing fertility treatments such as controlled ovarian hyperstimulation. It works by inhibiting surges of luteinizing hormone, or LH, a chemical messenger that helps trigger reproductive processes like ovulation. Ganirelix can be a helpful treatment for women who are struggling to conceive naturally.

Fresenius Kabi USA is delighted to introduce its newest addition to its Women’s Health portfolio: Ganirelix Acetate Injection. This latest development offers hopeful parents a wider selection of options for their in vitro fertilization or other fertility treatments.

John Ducker, President and CEO of Fresenius Kabi USA, expresses his enthusiasm for this new venture as it continues to help those in search of a successful family creation.

Expand your reproductive health options with Fresenius Kabi’s Women’s Health portfolio! In addition to Chorionic Gonadotropin for Injection, USP (hCG) and Progesterone Injection, USP, you can now get Ganirelix Acetate Injection as part of the ever-growing range of products that have been specially designed to empower and support women. Help create a healthier, happier world with Fresenius Kabi!

The Society for Assisted Reproductive Technology (SART) has released recent national figures displaying a whopping 44 percent surge in Assisted Reproductive Technology (ART) cycles over the last six years. This could be attributable to the restart of post-COVID services as well as the mounting demand for such technology. Astonishingly, ART cycles now account for more than two percent of all births in the US.

Ganirelix Acetate Injection, available from Fresenius Kabi, offers a preservative- and latex-free generic equivalent to Organon’s original version. By providing a therapeutic dosage of 250 mcg/0.5 mL, this injection provides reliable, long-term relief from hormone balance-related issues.

Leave a Comment